Floatz logo

277 assets in Small Cell Lung Carcinoma

Therapeutic assets addressing Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
ic9.gd2.car.il-15 t-cells
Small Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterEarly P1C (38)
Nogapendekin Alfa Inbakicept
Small Cell Lung Carcinoma
ImmunityBio, Inc.P2C (38)
Acetazolamide
Small Cell Lung Carcinoma
Centre Antoine LacassagneP1C (37)
Bbi-355
Small Cell Lung Carcinoma
Boundless Bio, Inc.P1C (37)
Bbi-825
Small Cell Lung Carcinoma
Boundless Bio, Inc.P1C (37)
bg-68501
Small Cell Lung Carcinoma
BeiGeneP1C (37)
Bgb-43395
Small Cell Lung Carcinoma
BeiGeneP1C (37)
bt02
Small Cell Lung Carcinoma
Biotroy TherapeuticsP1C (37)
dxc014
Small Cell Lung Carcinoma
Hangzhou DAC Biotechnology Co., Ltd.P1C (37)
Fenretinide
Small Cell Lung Carcinoma
SciTech Development, Inc.P1C (37)
Futibatinib
Small Cell Lung Carcinoma
Boundless Bio, Inc.P1C (37)
ibi3009
Small Cell Lung Carcinoma
Innovent Biologics (Suzhou) Co. Ltd.P1C (37)
imm2520
Small Cell Lung Carcinoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1C (37)
Janx008
Small Cell Lung Carcinoma
Janux TherapeuticsP1C (37)
nkt3964
Small Cell Lung Carcinoma
NiKang Therapeutics, Inc.P1C (37)
Nms-03305293
Small Cell Lung Carcinoma
Nerviano Medical SciencesP1C (37)
sys6040 for
Small Cell Lung Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd.P1C (37)
sys6043
Small Cell Lung Carcinoma
Conjupro Biotherapeutics, Inc.P1C (37)
Vobramitamab Duocarmazine
Small Cell Lung Carcinoma
MacroGenicsP2C (36)
Ink Cells
Small Cell Lung Carcinoma
Guangzhou Ruixin Biotechnological Co., LTDEarly P1C (34)
R130
Small Cell Lung Carcinoma
Shanghai Yunying Medical TechnologyEarly P1C (34)
Yishen Qutong Simulant Granules
Small Cell Lung Carcinoma
LI FENGN/AD (30)
Htmc0435
Small Cell Lung Carcinoma
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.P1/2NR ()
Obrixtamig
Small Cell Lung Carcinoma
Boehringer IngelheimP1NR ()
Showing 251 to 276 of 276 assets
PreviousPage 6 of 6Next